1.           Introduction

1.1       Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1         Hypothesis formulation:

3.2.2         Macroeconomic factor analysis:

3.2.3         Developing base number:

3.2.4         Data Triangulation:

3.2.5         Country-level data:

4.           North America Clinical Trials Market Landscape

4.1       Overview

4.2       PEST Analysis

5.           North America Clinical Trials Market – Key Market Dynamics

5.1       Market Drivers

5.1.1         Practice of Outsourcing Clinical Studies with Massive Rise in Number of Trials

5.1.2         Flourishing Pharmaceutical Industry with Surge in R&D Activities

5.2       Market Restraints

5.2.1         Expensive and Time-Consuming Process

5.3       Market Opportunities

5.3.1         Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials

5.4       Future Trends

5.4.1         AI-Driven Clinical Trials

5.5       Impact of Drivers and Restraints:

6.           Clinical Trials Market – North America Analysis

6.1       North America Clinical Trials Market Revenue (US$ Million), 2021–2031

6.2       North America Clinical Trials Market Forecast Analysis

7.           North America Clinical Trials Market Analysis – by Study Design

7.1       Interventional Trials

7.1.1         Overview

7.1.2         Interventional Trials: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2       Expanded Access Trials

7.2.1         Overview

7.2.2         Expanded Access Trials: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.           North America Clinical Trials Market Analysis – by Indications

8.1       Autoimmune/Inflammation

8.1.1         Overview

8.1.2         Autoimmune/Inflammation: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2       Pain Management

8.2.1         Overview

8.2.2         Pain Management: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.3       Oncology

8.3.1         Overview

8.3.2         Oncology: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.4       Neurological Disorders

8.4.1         Overview

8.4.2         Neurological Disorders: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.5       Diabetes

8.5.1         Overview

8.5.2         Diabetes: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.6       Obesity

8.6.1         Overview

8.6.2         Obesity: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.7       Metabolic Disorders

8.7.1         Overview

8.7.2         Metabolic Disorders: North America Clinical Trials Market – Revenue and Forecast, 2021–2031  (US$ Million)

8.8       Cardiovascular

8.8.1         Overview

8.8.2         Cardiovascular: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.9       Others

8.9.1         Overview

8.9.2         Others: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.           North America Clinical Trials Market Analysis – by Phase Type

9.1       Phase I

9.1.1         Overview

9.1.2         Phase I: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.2       Phase II

9.2.1         Overview

9.2.2         Phase II: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.3       Phase III

9.3.1         Overview

9.3.2         Phase III: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.        North America Clinical Trials Market – Country Analysis

10.1     North America

10.1.1       North America Clinical Trials Market – Revenue and Forecast Analysis – by Country

10.1.1.1          North America Clinical Trials Market – Revenue and Forecast Analysis – by Country

10.1.1.2          United States: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.2.1        United States: North America Clinical Trials Market Share – by Study Design

10.1.1.2.2        United States: North America Clinical Trials Market Share – by Indications

10.1.1.2.3        United States: North America Clinical Trials Market Share – by Phase Type

10.1.1.3          Canada: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.3.1        Canada: North America Clinical Trials Market Share – by Study Design

10.1.1.3.2        Canada: North America Clinical Trials Market Share – by Indications

10.1.1.3.3        Canada: North America Clinical Trials Market Share – by Phase Type

10.1.1.4          Mexico: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.4.1        Mexico: North America Clinical Trials Market Share – by Study Design

10.1.1.4.2        Mexico: North America Clinical Trials Market Share – by Indications

10.1.1.4.3        Mexico: North America Clinical Trials Market Share – by Phase Type

11.        Industry Landscape

11.1     Overview

11.2     Growth Strategies in Clinical Trials Market

11.3     Organic Growth Strategies

11.3.1       Overview

11.4     Inorganic Growth Strategies

11.4.1       Overview

12.        Company Profiles

12.1     QVIA Holdings Inc

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Products and Services

12.1.4       Financial Overview

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2     Parexel International Corp

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Products and Services

12.2.4       Financial Overview

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3     IXICO Plc

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Products and Services

12.3.4       Financial Overview

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4     Charles River Laboratories International Inc

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Products and Services

12.4.4       Financial Overview

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5     ICON Plc

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Products and Services

12.5.4       Financial Overview

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6     WuXi AppTec Co Ltd

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Products and Services

12.6.4       Financial Overview

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7     SGS SA

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Products and Services

12.7.4       Financial Overview

12.7.5       SWOT Analysis

12.7.6       Key Developments

12.8     Syneos Health Inc

12.8.1       Key Facts

12.8.2       Business Description

12.8.3       Products and Services

12.8.4       Financial Overview

12.8.5       SWOT Analysis

12.8.6       Key Developments

12.9     SIRO Clinpharm Pvt Ltd

12.9.1       Key Facts

12.9.2       Business Description

12.9.3       Products and Services

12.9.4       Financial Overview

12.9.5       SWOT Analysis

12.9.6       Key Developments

12.10  Thermo Fisher Scientific Inc

12.10.1    Key Facts

12.10.2    Business Description

12.10.3    Products and Services

12.10.4    Financial Overview

12.10.5    SWOT Analysis

12.10.6    Key Developments

12.11  Laboratory Corp of America Holdings

12.11.1    Key Facts

12.11.2    Business Description

12.11.3    Products and Services

12.11.4    Financial Overview

12.11.5    SWOT Analysis

12.11.6    Key Developments

12.12  CliniRx Research Private Limited

12.12.1    Key Facts

12.12.2    Business Description

12.12.3    Products and Services

12.12.4    Financial Overview

12.12.5    SWOT Analysis

12.12.6    Key Developments

12.13  Caidya

12.13.1    Key Facts

12.13.2    Business Description

12.13.3    Products and Services

12.13.4    Financial Overview

12.13.5    SWOT Analysis

12.13.6    Key Developments

12.14  Oracle Corp

12.14.1    Key Facts

12.14.2    Business Description

12.14.3    Products and Services

12.14.4    Financial Overview

12.14.5    SWOT Analysis

12.14.6    Key Developments

12.15  Medpace Holdings Inc

12.15.1    Key Facts

12.15.2    Business Description

12.15.3    Products and Services

12.15.4    Financial Overview

12.15.5    SWOT Analysis

12.15.6    Key Developments

13.        Appendix

13.1     About Us

13.2     List of Abbreviations

List of Tables

Table 1.             North America Clinical Trials Market Segmentation

Table 2.             R&D Investments by Major Pharmaceutical Companies

Table 3.             North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Table 4.             North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Study Design

Table 5.             North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications

Table 6.             North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Phase Type

Table 7.             North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country

Table 8.             United States: North America Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 9.             United States: North America Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 10.          United States: North America Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 11.          Canada: North America Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 12.          Canada: North America Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 13.          Canada: North America Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 14.          Mexico: North America Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 15.          Mexico: North America Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 16.          Mexico: North America Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 17.          Recent Organic Growth Strategies in Clinical Trials Market

Table 18.          Recent Inorganic Growth Strategies in the Clinical Trials Market

Table 19.          List of Abbreviations

List of Figures

Figure 1.           North America Clinical Trials Market Segmentation – Country

Figure 2.           PEST Analysis

Figure 3.           North America Clinical Trials Market – Key Market Dynamics

Figure 4.           Impact Analysis of Drivers and Restraints

Figure 5.           North America Clinical Trials Market Revenue (US$ Million), 2021–2031

Figure 6.           North America Clinical Trials Market Share (%) – by Study Design (2023 and 2031)

Figure 7.           Interventional Trials: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8.           Expanded Access Trials: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 9.           North America Clinical Trials Market Share (%) – by Indications (2023 and 2031)

Figure 10.        Autoimmune/Inflammation: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11.        Pain Management: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 12.        Oncology: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 13.        Neurological Disorders: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 14.        Diabetes: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 15.        Obesity: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16.        Metabolic Disorders: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 17.        Cardiovascular: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 18.        Others: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 19.        North America Clinical Trials Market Share (%) – by Phase Type (2023 and 2031)

Figure 20.        Phase I: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 21.        Phase II: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 22.        Phase III: North America Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 23.        North America Clinical Trials Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 24.        United States: North America Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 25.        Canada: North America Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 26.        Mexico: North America Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 27.        Growth Strategies in Clinical Trials Market